United States · Platforms & data · GuruFocus

enGene Therapeutics (ENGN) Shares Surge 20% on Positive Phase 2 Trial Update

Published by GuruFocus · United States 2 h ago

Read the full article on GuruFocus Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

The Motley Fool

Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It

I inherited $1.4 million from my father. Am I wrong to ask my husband of 25 years for a postnuptial agreement?

Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapy

Altimmune outlines $480M cash runway through 2029 PERFORMA readout as RESTORE data targeted for 2H 2027

Oil prices rise after Trump says no Iran deal needed: 'We've got their Strait'

Grupo Equatorial Q3 2026 slides: EBITDA rises amid debt pressures